Melodie Domurad, PhD
![](https://www.dayzerodiagnostics.com/wp-content/uploads/2022/03/Melodie-030321.png)
A medical, clinical and regulatory affairs professional with over 25 years of experience in the development, design, and implementation of phase I-IV clinical trials of IVDs and therapeutic devices. The architect of multiple successful regulatory submissions to the FDA and international authorities, including IDE, 510(k), de novo, PMA and CE. She has a BA from Cornell University and a PhD from the University of Cincinnati.